MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Combitide Starhaler for Asthma and COPD

Combitide Starhaler for asthma and COPD is a 60-dose dry powder inhaler containing a steroid and a beta agonist formulation. It is designed to treat patients with asthma or COPD, using a novel de-agglomeration engine to separate the drug from the carrier particles. Manufactured by Sun Pharmaceutical Industries Ltd. (Mumbai, India). Entry submitted by Cambridge Consultants Ltd. (Cambridge, UK). Supply and design credit to Design Directions (Pune, India), Sun Pharma Advanced Research Co. Ltd. (Vadodara, India), Foboha GmbH (Haslach, Germany), and Nypro Forbes Pvt. Ltd.

Combitide Starhaler for asthma and COPD is a 60-dose dry powder inhaler containing a steroid and a beta agonist formulation. It is designed to treat patients with asthma or COPD, using a novel de-agglomeration engine to separate the drug from the carrier particles. Manufactured by Sun Pharmaceutical Industries Ltd. (Mumbai, India). Entry submitted by Cambridge Consultants Ltd. (Cambridge, UK). Supply and design credit to Design Directions (Pune, India), Sun Pharma Advanced Research Co. Ltd. (Vadodara, India), Foboha GmbH (Haslach, Germany), and Nypro Forbes Pvt. Ltd. (Hosur, India).


 

 

Previous Finalist

Next Finalist

Back to Categories

Hide comments
account-default-image

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish